Notable Labs
YC W15YC Top CompanySan Francisco, US · Founded 2014 · Delaware corporation · 40 employees · Public · Hiring · 37 known investors
Find your way into Notable Labs
Sign up to see every warm intro you have to Notable Labs
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Notable Labs team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Notable Labs operates an automated laboratory that tests combinations of existing drugs against individual patients' blood cancer cells to identify effective treatment options for patients whose cancers have become resistant to standard therapies.
Also known as Stemcycle Inc.
Founders & leadership· Y Combinator alumni (W15)
Notable Labs was founded in 2014 by Matthew De Silva and Pete Quinzio.

Investors · 37
How we know: 11.2 Capital's portfolio page · open dataset · 5k.vc investor directory · Y Combinator's founder network · Not right? Tell us
How we know: av.vc · Not right? Tell us
How we know: Builders VC's portfolio page · a partner's Signal profile · board seat on SEC Form D · Y Combinator's founder network · Not right? Tell us
How we know: FundersClub's portfolio page · Y Combinator's founder network · Not right? Tell us
How we know: Hemisphere Ventures LLC's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Lifeforce Capital's portfolio page · a partner's Signal profile · the VCSheet dataset · open dataset · 5k.vc investor directory · Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Nat Turner's portfolio page · Not right? Tell us
How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: board seat on SEC Form D · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: funding news · Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$82.2M disclosed across 6 rounds · 2014–2023
▶$10.3MraisedMar 2023 · 26 investors · BiotechnologyRule 506(b)
- Joseph WagnerExecutive Officer
- Matthew De SilvaDirector
- Adam SeabrookDirector
- James KimDirector
- Thomas BockExecutive Officer, Director
- Offering amount
- $10.3M
- Amount sold
- $10.3M
- Sales commissions
- $310.1K
- Placement agents
- JMP Securities LLC
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10.1MraisedJul 2022 · 19 investors · BiotechnologyRule 506(b)
- James KimDirector
- Adam SeabrookDirector
- Matthew De SilvaDirector
- Thomas BockExecutive Officer, Director
- Offering amount
- $10.5M
- Amount sold
- $10.1M
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$39.8MraisedDec 2019 · 37 investors · BiotechnologyRule 506(b)
- Matthew De SilvaExecutive Officer, Director
- Michael HorowitzExecutive Officer
- James KimDirector
- Peter QuinzioExecutive Officer, Director
- Offering amount
- $44M
- Amount sold
- $39.8M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$14.8MraisedAug 2017 · 95 investors · Other Health CareRule 506(c)
- James KimDirector
- Matthew De SilvaExecutive Officer, Director, Promoter
- Pete QuinzioExecutive Officer, Director, Promoter
- Amanda HermannExecutive Officer
- Offering amount
- $17.7M
- Amount sold
- $14.8M
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06c
▶$2.7MraisedMar 2017 · 23 investors · BiotechnologyRule 506(b)
- Peter QuinzioExecutive Officer
- Matthew De SilvaExecutive Officer, Director
- Offering amount
- $2.7M
- Amount sold
- $2.7M
- Proceeds to insiders
- $300K
- First sale
- May 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$4.5MraisedMay 2016 · 40 investors · BiotechnologyRule 506(b)
- Matthew De SilvaExecutive Officer, Director
- Peter QuinzioExecutive Officer
- Offering amount
- $4.5M
- Amount sold
- $4.5M
- Proceeds to insiders
- $300K
- First sale
- Jul 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
The YC application· Winter 2015 batch
Related companies · 5
Companies working in the same space as Notable Labs.
Legal entities · 2
corporate structureFrequently asked questions
- What does Notable Labs do?
- Notable Labs operates an automated laboratory that tests combinations of existing drugs against individual patients' blood cancer cells to identify effective treatment options for patients whose cancers have become resistant to standard therapies.
- Who founded Notable Labs?
- Notable Labs was founded by Matthew De Silva, Pete Quinzio in 2014.
- Who are Notable Labs's investors?
- Notable Labs's investors include 11.2 Capital, Alumni Ventures, Builders VC, FundersClub, Gaingels, Hemisphere Ventures LLC, Lifeforce Capital, Mission and Market and 29 more.
- How much funding has Notable Labs raised?
- Notable Labs has disclosed $82.2M raised across 6 rounds.
- Where is Notable Labs headquartered?
- Notable Labs is headquartered in San Francisco, US.





__Twitter.png)



.jpeg)













